The U.S. Food and Drug Administration just issued a call for applications for the next cohort of the Patient Engagement Collaborative (PEC). The PEC, established in 2018 in collaboration with the Clinical Trials Transformation Initiative (CTTI), is a group of patient organizations and individual representatives who discuss ways to enhance patient engagement. CTTI and the FDA collaborate to involve representatives with a variety of perspectives including patients, caregivers and representatives from diverse patient organizations.
Understanding patients’ experiences is critical to support medical product regulation and help ensure safe, effective and innovative medical products are available,” said Andrea C. Furia-Helms, M.P.H., Director of Patient Affairs, Office of Clinical Policy and Programs.
The call for applications is to identify individuals interested in serving as members of the PEC. The application period is open for 30 days. PEC members are expected to serve for two to three years. A selection committee consisting of patient advocates, staff from CTTI, the FDA and patient representatives, will select individuals to serve as members following this formal call for applications.
Edited by Michael Causey
